Phoenix, AZNCT07187479Now EnrollingIRB Ready

Chronic Kidney Disease (Stages 4 and 5) Clinical Trial in Phoenix, AZ

Access cutting-edge chronic kidney disease (stages 4 and 5) treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.

Sponsored by Well Cell Global

Quick Self-Assessment

See if you qualify for this Phoenix location

Preparing your pre-screening questions…

Expert Care in Phoenix

Access chronic kidney disease (stages 4 and 5) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic kidney disease (stages 4 and 5) treatment provided free

Apply for This Phoenix Location

Check if you qualify for this chronic kidney disease (stages 4 and 5) clinical trial in Phoenix, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Phoenix

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Phoenix site if eligible
  4. 4Begin participation

About This Chronic Kidney Disease (Stages 4 and 5) Study in Phoenix

The purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).

Sponsor: Well Cell Global

Who Can Participate

Inclusion Criteria

Is age 18 or older (male or female)
Have a documented diagnosis of CKD stage 3b, 4, or 5 and T2DM of 6 months or greater prior to screening. Patients may have treatment regimens associated with T2DM that include diabetic oral and/or injectable medications including insulin and/or GLP-1 receptor agonists.
In the opinion of the Investigator, has been on an appropriate, stable regimen for management of any complications present for the past six (6) months.
In the opinion of the Investigator, is able to do all of the following:
Provide valid informed consent.
Understand and comply with study procedures as presented in the consent process.
Has the capacity or support to attend all required visits.
If female, the subject must meet either of the following sets of conditions: o Is of non-childbearing potential, defined as meeting either of the following criteria:
Age ≥50 years and post-menopausal for at least one (1) year
Surgically sterile due to bilateral tubal ligation, bilateral oophorectomy, or hysterectomy
Is of childbearing potential and meets both of the following criteria:
Has a negative serum pregnancy test (beta-human chorionic gonadotropin) at screening.
Agrees to practice an acceptable method of birth control (contraception) from screening until at least 30 days after last study treatment

Exclusion Criteria

Has in the past two (2) years received treatment for a malignancy.
Current pregnancy or intends to become pregnant during the study
Has in the past one (1) year used non-prescription opioids or psychoactive drugs.
Has in the past six (6) months had a hypoglycemic event requiring urgent care and/or administration of glucagon, osteocalcin, or parenteral glucose, unless approved for enrollment by the Medical Monitor.
Has within the past one (1) month participated in a clinical study involving either of the following:
An investigational drug or procedure for any clinical indication
An investigation method for glucose control using approved agents
Is nursing or is planning to nurse during the study.
Has at screening a positive test for HIV (4th gen. screen), HBsAg, or HCV viral load.
Has at screening, one or more of the following abnormal lab results:
Hb \<8 g/dL
WBC \<2,000/µL
Platelets \<50,000/µL
ALT, AST, or Alkaline Phosphatase \>5x ULN
ALT or AST \>2.5x ULN, and Total Bilirubin \>2x ULN
Serum albumin \<3 g/dL
Has - in the opinion of the Investigator - psychiatric, behavioral, cognitive and/or clinical dysfunction (whether or not related to known medical illness or drug / alcohol use) that would affect the subject's safety and/or compliance.
Is on active dialysis at time of screening

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Phoenix?

Yes, this clinical trial (NCT07187479) has an active research site in Phoenix, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Kidney Disease (Stages 4 and 5) Treatment Options in Phoenix, AZ

If you're searching for chronic kidney disease (stages 4 and 5) treatment options in Phoenix, AZ, this clinical trial (NCT07187479) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease (stages 4 and 5) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic kidney disease (stages 4 and 5) clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Phoenix, AZ

See all ankylosing spondylitis clinical trials recruiting in Phoenix — not just this study.

Browse Ankylosing Spondylitis Trials in Phoenix →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsChronic Kidney Disease TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Phoenix?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Phoenix, AZ